Global Clinical Outsourcing Industry Report

We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights click here. By clicking the "Download button" you agree to the terms of our Privacy Policy.

The number of clinical trials being outsourced is increasing and the industry is working together to develop ground-breaking partnerships that focus on creative contracting and effective oversight.
According to a recent report, more than a third of clinical trials conducted by Pharma organisations are now being outsourced to vendors and expenditure on clinical trial outsourcing has also increased with the amount of global research and development expenditure allotted to the outsourced drug developers reaching $36.6 billion last year. Whether you are a big Pharma organisation or small Biotech, the relationship between sponsor and CRO is crucial to maximise the efficiency of clinical trials.

This whitepaper gives you an up-to-date overview of the evolving nature of the outsourcing market and points to the challenges and opportunities that working with a CRO can bring. Case studies and included videos deliver industry best-practice and experiences on how to nurture and prosper from a successful relationship with your CRO.